Inventor
GJALT W. HUISMAN
Inventor
US
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes25%
C12YEnzymes24%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture13%
A61KPreparations for medical, dental or toiletry purposes12%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
Y02PClimate change mitigation technologies in the production or processing of goods8%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution4%
C07KPeptides1%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms1%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology1%
PatentTitleYear
12,497,605Engineered acid alpha-glucosidase variants202512,421,532Polynucleotides encoding engineered imine reductases202512,415,990Ketoreductase polypeptides for the reduction of acetophenones202512,378,585Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane202512,371,674Enone reductases202512,365,927Engineered ketoreductase polypeptides202512,286,655Human alpha-galactosidase variants202512,263,207Human alpha-galactosidase variants202512,257,291Human alpha-galactosidase variants202512,129,494T7 RNA polymerase variants202412,110,521Engineered methionine gamma lyase variants202411,970,722Engineered acid alpha-glucosidase variants202411,965,194Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane202411,913,045Engineered phenylalanine ammonia lyase polypeptides202411,618,911Engineered imine reductases and methods for the reductive amination of ketone and amine compounds202311,535,845Automated screening of enzyme variants202211,512,332Engineered ketoreductase polypeptides202211,497,798Human alpha-galactosidase variants202211,479,756Ketoreductase polypeptides for the reduction of acetophenones202211,427,841Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane202211,427,813Human alpha-galactosidase variants202211,421,253Engineered tyrosine ammonia lyase202211,401,515Engineered phenylalanine ammonia lyase polypeptides202211,377,673Engineered imine reductases and methods for the reductive amination of ketone and amine compounds202211,278,600Human alpha-galactosidase variants202211,236,311T7 RNA polymerase variants202211,236,312T7 RNA polymerase variants202211,136,571Engineered phenylalanine ammonia lyase polypeptides2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to CODEXIS INC (23)· patent assignee history
2021–2025Based in US· patent location history
2024Patents assigned to SYNTIS BIO INC (1)· patent assignee history
2025Patents assigned to CROSSWALK THERAPEUTICS INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CODEXIS INC | 23 | 2021–2025 |
| CROSSWALK THERAPEUTICS INC | 4 | 2025 |
| SYNTIS BIO INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 28 | 2021–2025 |